Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
26.88
-0.33 (-1.21%)
At close: May 18, 2026, 4:00 PM EDT
26.82
-0.06 (-0.22%)
After-hours: May 18, 2026, 7:54 PM EDT
Greenwich LifeSciences Employees
As of December 31, 2024, Greenwich LifeSciences had 8 total employees, including 4 full-time and 4 part-time employees. The number of employees increased by 1 or 14.29% compared to the previous year.
Employees
8
Change (1Y)
1
Growth (1Y)
14.29%
Revenue / Employee
n/a
Profits / Employee
-$2,434,463
Market Cap
372.41M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 8 | 1 | 14.29% | 4 | 4 |
| Dec 31, 2023 | 7 | 1 | 16.67% | 3 | 4 |
| Dec 31, 2022 | 6 | 0 | - | 3 | 3 |
| Dec 31, 2021 | 6 | 3 | 100.00% | 3 | 3 |
| Dec 31, 2020 | 3 | - | - | 1 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Puma Biotechnology | 179 |
| Lyell Immunopharma | 161 |
| Enanta Pharmaceuticals | 120 |
| C4 Therapeutics | 104 |
| Verastem | 102 |
| InflaRx | 65 |
| Lexeo Therapeutics | 59 |
GLSI News
- 18 days ago - Greenwich LifeSciences says Form 10-K ‘still being audited’ - TheFly
- 18 days ago - Greenwich LifeSciences Provides Update Regarding Form 10-K Filing - GlobeNewsWire
- 25 days ago - Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026 - GlobeNewsWire
- 26 days ago - Greenwich LifeSciences receives noncompliance notification from Nasdaq - TheFly
- 26 days ago - Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing - GlobeNewsWire
- 4 weeks ago - Greenwich LifeSciences presents Flamingo-01 Phase 3 results from AACR 2026 - TheFly
- 4 weeks ago - Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026 - GlobeNewsWire
- 4 weeks ago - Greenwich LifeSciences reports cash balance of $10.5M as of March 31 - TheFly